Review Article
Thirty Years with HIV Infection—Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors
Table 2
Immunological distinctions between progressors and non-progressors.
| | Controller | LTNP | Progressor |
| Production of T cells | Thymic output preserved | Thymus output? | Thymic output ↓ | Haematopoiesis preserved | Haematopoiesis? | Haematopoiesis exhausted |
| IL-7/IL-7R | IL-7 Normal | IL-7 ↑ | IL-7 ↑ | IL-7R Normal | IL-7R ↓ | IL-7R ↓ |
| Destruction of T cells | Immune activation ↑ | Immune activation ↑↑ | Immune activation ↑↑↑ | Turnover/apoptosis ↑ | Turnover/apoptosis? | Turnover/apoptosis ↑↑ | Microbial translocation ↑ | ? Microbial translocation | ↑↑↑Microbial translocation |
| Secondary lymphoid tissue | Preserved architecture | ? | Damaged architecture |
| Pro- and anti-inflammatory cells | ↓Tregs | ? Tregs | ↑↑Tregs | ↑Th17 | ↑Th17 | ↓Th17 |
| HIV-specific immune response | Strong | ? | Blunted |
| Viral reservoir | Low | ? | High |
|
|
↑/↓: Indicates slightly, ↑↑/↓↓: moderate, ↑↑↑/↓↓ ↓: highly different from HIV-negative individuals. LTNP: long-term non-progressors, Tregs: regulatory T cells. ?: Indicates unknown.
|